Is BCSSX or JNJ a better dividend investment in 2026?

BCSSX currently yields 122.06% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: BCSSX offers higher current income.

What is the dividend yield difference between BCSSX and JNJ?

BCSSX has a forward dividend yield of 122.06% ($23.59/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 118.70 percentage points.

Home › Compare › BCSSX vs JNJ

BCSSX vs JNJ: Dividend Comparison 2026

BCSSX yields 122.06% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BCSSX wins by $9.21M in total portfolio value

INVESTMENT

TIME HORIZON10 years

BCSSX

● Live price

122.06%

Share price

$19.33

Annual div

$23.59

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$9.23M

Annual income

$3,535,598.40

Full BCSSX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — BCSSX vs JNJ

📍 BCSSX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BCSSX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BCSSX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BCSSX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BCSSX

Annual income on $10K today (after 15% tax)

$10,374.84/yr

After 10yr DRIP, annual income (after tax)

$3,005,258.64/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, BCSSX beats the other by $3,004,555.03/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BCSSX + JNJ for your $10,000?

BCSSX: 50%JNJ: 50%

100% JNJ50/50100% BCSSX

Portfolio after 10yr

$4.63M

Annual income

$1,768,213.09/yr

Blended yield

38.22%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BCSSX

No analyst data

Altman Z

1.1

Piotroski

7/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BCSSX buys

JNJ buys

No recent congressional trades found for BCSSX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBCSSXJNJ

Forward yield	122.06% ✓	3.36%
Annual dividend / share	$23.59 ✓	$4.96
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$9.23M	$20.0K ✓
Annual income after 10y	$3,535,598.40 ✓	$827.78
Total dividends collected	$8.41M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: BCSSX vs JNJ ($10,000, DRIP)

Year	BCSSX Portfolio	BCSSX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$22,906	$12,205.69	$10,676	$355.77	+$12.2K → BCSSX
2	$50,638	$26,128.95	$11,407	$389.39	+$39.2K → BCSSX
3	$108,168	$53,984.82	$12,198	$426.53	+$96.0K → BCSSX
4	$223,512	$107,772.49	$13,056	$467.62	+$210.5K → BCSSX
5	$447,284	$208,126.60	$13,987	$513.12	+$433.3K → BCSSX
6	$867,843	$389,248.55	$14,998	$563.56	+$852.8K → BCSSX
7	$1,634,422	$705,830.89	$16,098	$619.52	+$1.62M → BCSSX
8	$2,991,171	$1,242,339.35	$17,295	$681.69	+$2.97M → BCSSX
9	$5,325,429	$2,124,875.24	$18,599	$750.82	+$5.31M → BCSSX
10	$9,233,807	$3,535,598.40	$20,022	$827.78	+$9.21M → BCSSX

BCSSX vs JNJ: Complete Analysis 2026

BCSSX — Stock

The fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of those companies with total operating revenues of $500 million or less at the time of the initial investment. It typically invests in common stocks. The advisor seeks to build a portfolio of exceptional small companies with the wherewithal to become exceptional large companies. The fund typically holds a portfolio of between 40 - 65 securities which the advisor believes have the potential for growth.

Full BCSSX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this BCSSX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BCSSX vs SCHD BCSSX vs JEPI BCSSX vs O BCSSX vs KO BCSSX vs MAIN BCSSX vs ABBV BCSSX vs MRK BCSSX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.